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A B S T R A C T
Objective: To identify morbidity and mortality risk factors in patients with synchronous diseases who
underwent single-stage combined (SSC) surgery.
Methods: We considered data of 328 patients, each with multiple, elective, synchronous surgical problems
treated by a SSC operation. By univariate and multivariate analysis we evaluated many patient -, disease- or
treatment -related variables with respect to post-operative mortality, morbidity, and hospital stay.
Results: Two combined procedures were synchronously performed in 283 patients (86%), 3 combined
procedures in 45 patients (14%). Post-operative mortality and morbidity rates were 3% and 24%, respectively,
and median duration of hospital stay was 9 days. The occurrence of a surgical oncology procedure emerged
as the most important independent risk factor for post-operative mortality and morbidity.
Conclusions: The safety of SSC surgery for the treatment of synchronous problems appears similar to that of
multi-stage procedures. The understanding of risk factors for this surgical approach could be useful in order
to improve patient selection.
© 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.
1. Introduction
With the population aging in the Western world, the incidence
of some age-related surgical diseases has continuously increased. 1
Additionally, the diffusion of cancer screening programs and the
development of imaging techniques additionally allowed diagnosis of
asymptomatic disorders in surgical patients. 2 Hence, today there is
a relatively high incidence (approximately 10%) of patients requiring
single-stage combined (SSC) surgery for synchronous problems. 3
In the present surgical environment, patients could be offered the
convenience of a single operation and anesthesia (SSC approach)
for combined multispecialty procedures. However, the trend towards
surgical specialization typically leads a surgeon, even though capable
of performing different types of surgery, to refer patients to another
surgeon for any operation outside his subspecialization. 3 Further-
more, the present climate of litigation might be a contributing factor,
and surgeons may feel safer if they conﬁne their activity to a narrow
procedural spectrum. Thus, the unknown potential hazards related
to several surgical procedures performed at the same time made
surgeons reluctant to introduce another subspecialty, even though
they are competent in it. In the literature, there is already extensive
documentation of the multispecialty workload of many surgeons
working in rural or underdeveloped areas, 4,5 but this problem
is spreading. To date, the well-known concomitant occurrence of
abdominal aortic aneurysm and an abdominal malignancy does not
represent the only therapeutic dilemma. 6,7 Multiple surgical diseases
also occur synchronously, with increasing frequency, in the ﬁelds of
cardiothoracic 8,9 and gastrointestinal (GI) surgery. 10–12
The main controversy revolves around whether it is better to
treat lesions with single-stage combined or with multi-stage (MS)
procedures.
This retrospective study on a large series of SSC procedures aims
to calculate the morbidity and mortality rates associated with the
SSC approach and to identify the factors to be considered in selecting
patients for this strategy.
2. Patients and methods
From January 1991 to December 2012, 328 patients (167 males,
161 females; median age 66 years, range 15–89 years) underwent
SSC procedures. The present analysis excluded patients treated in
emergency or day-surgery setting as these conditions signiﬁcantly
affect the diagnostic work-up and the surgical strategy. Combined
surgical procedures performed for well-deﬁned technical needs (e.g.,
splenectomy associated with distal pancreatectomy for cancer) were
not considered.
For all patients medical records, surgical reports and pathologic
data were reviewed.
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2.1. End-points and risk factors
The end-points of this study were post-operative in-hospital mor-
tality, morbidity (i.e. incidence of medical and/or surgical complica-
tions), and length of stay.
In order to detect the risk factors correlated with the end-points,
patient-, disease-, and treatment -related variables were considered.
Patient -related factors were age, gender, cardiovascular/pulmonary/
diabetic comorbidities, prior major surgery, prior malignancies,
and pre-operative hemoglobin level. Disease-related factors were
POSSUMoperative severity, 13 anatomical region (soft tissues, GI tract,
vascular district, or other), and malignant origin. Finally, treatment -
related factorswere diagnosis time (pre-operative or intra-operative),
operative time, surgical team (with or without subspecialty surgeon),
number and kind of surgical accesses (minimally invasive approach,
too), surgical contamination grade, 14 and anastomosis.
For each patient the combination of SSC procedures (and all the
treated diseases) was analyzed. In order to obtain a total POSSUM
operative severity for the procedure combination a numerical value
was assigned to each difﬁculty grade (minor = 0; moderate = 1;
major = 2; major + = 3).
2.2. Statistical analysis
Results were expressed as percentages and median with range. For
analysis, continuous variables were categorized according to the
median value. The associations between end-points and patient-,
disease-, and treatment -related factors were analyzed by non-
parametric tests, as appropriate. Adjusting the covariates with p < 0.1
at bivariate analysis, a stepwise logistic regression model was built
to identify variables independently associated with end-points. The
statistical analysis was performed with SPSS software for Windows©.
All reported P values were two-sided. A P value <0.05 was considered
statistically signiﬁcant.
3. Results
Patient characteristics (patient -related variables) are detailed in
Table 1. A combination of two procedures was performed in
Table 1
Distribution of patient-related variables
Variable # %
Age (years)
66
163 49.7
>66 165 50.3
Gender
Males 167 50.0
Females 161 49.1
Cardiovascular/pulmonary/diabetic comorbidities
Yes 286 87.2
No 42 12.8
Prior major surgery
Yes 222 67.7
No 106 32.3
Prior malignancies
Yes 55 16.8
No 273 83.2
Preoperative hemoglobin level (g/dl)
12 78 23.8
>12 250 76.2
283 cases (86%) and a combination of three in 45 (14%). Median oper-
ative time was 150.5 minutes (range 40–540 minutes). One hundred
and ﬁfty patients (46%) underwent surgery for malignancy and in
most cases diagnosis and surgical planning were obtained in the pre-
operative phase. The ﬁrst and the second procedures most frequently
involved the GI tract, while the third almost always involved soft
tissues. The distributions of disease- and treatment-related variables
speciﬁed for individual procedures and for procedure combinations
are reported in Tables 2 and 3, respectively.
Table 2
Distribution of disease- and treatment-related variables speciﬁed for any
procedure
Variable Number (%)
First
procedure
Second
procedure
Third
procedure
Disease-related variables
POSSUM operative severity
Minor 36 (11) 116 (35.4) 26 (57.8)
Moderate 92 (28) 112 (34.1) 11 (24.4)
Major 124 (37.8) 59 (18) 5 (11.1)
Major + 76 (23.2) 41 (12.5) 3 (6.7)
Anatomical region
Soft tissues 41 (12.5) 110 (33.5) 21 (46.7)
Gastrointestinal tract 226 (68.9) 192 (58.5) 20 (44.4)
Vascular district 34 (10.4) 19 (5.8) 3 (6.7)
Other 27 (8.2) 7 (2.2) 1 (2.2)
Malignancy
Yes 124 (37.8) 65 (19.8) 7 (15.6)
No 204 (62.2) 263 (80.1) 38 (84.4)
Treatment-related variables
Time of diagnosis
Pre-operative 321 (97.9) 288 (87.8) 38 (84.4)
Intra-operative 7 (2.1) 40 (12.2) 7 (15.6)
Anastomosis
Yes 115 (35) 44 (13.4) 6 (13)
No 213 (65) 284 (86.6) 40 (87)
Minimally invasive approach
Yes 51 (15.5) 38 (11.6) 2 (4.4)
No 277 (84.5) 290 (88.4) 43 (95.6)
Contamination grade
Clean 142 (43.3) 191 (58.2) 31 (68.9)
Clean-contaminated 186 (56.7) 137 (41.8) 14 (31.1)
In the post-operative period 9 out of 328 patients (3%) died and
80 patients (24%) presented at least one post-operative complication.
With regard to these outcomes differentiated by subspecialty, post-
operative mortality rate after (combined) soft tissue surgery was
1% (1 out of 172 procedures) versus 3% (15/438) and 5% (3/56) after
(combined) GI surgery and vascular surgery, respectively; similarly,
the complication rate after (combined) soft tissues surgery was
17% (30/172), versus 29% (126/438) and 25% (14/56) after (combined)
GI surgery and vascular surgery, respectively.
The median length of post-operative stay was 9 days (range 1–57
days), with half of the patients (158/328, 48%) experiencing a stay
>9 days.
There are no statistically signiﬁcant differences relative to the end-
points between patients who underwent two combined procedures
and patients who underwent three combined procedures.
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Table 3
Distribution of disease- and treatment-related variables speciﬁed
for combined procedures
Variable Combined procedures, # (%)
Disease-related variables
POSSUM operative severity
0–1 73 (22.3)
2–3 150 (45.7)
4–6 105 (32)
Surgical accesses
1 221 (67.4)
2 105 (32)
3 2 (0.6)
Malignancies
0 178 (54.3)
1 150 (45.7)
Treatment-related variables
Operative time
150 min 162 (49.4)
>150 min 166 (50.6)
Anastomoses
0 175 (53.3)
1 141 (43)
>1 12 (3.7)
Minimally invasive approaches
0 267 (81.5)
1 33 (10)
>1 28 (8.5)
Surgical teams
1 274 (83.5)
>1 54 (16.5)
Subspecialty surgeon
Yes 65 (19.8)
No 263 (80.2)
The results of univariate and multivariate analysis are presented in
Table 4. The stepwise modality selected operative time, malignant
origin and POSSUM operative severity associated with the treated
diseases as independent predictive factors for post-surgical morbidi-
ties; operative time and malignancy were independent predictive
factors for longer post-operative stay. Finally, the regression model
calculated for mortality selected only malignant origin associated
with the treated diseases as independent predictive factor.
4. Discussion
The concomitant occurrence of multiple surgical diseases still re-
mains a therapeutic dilemma,mainlywith respect towhich should be
treated ﬁrst. The surgeon must take into account the single operative
risks related to each single problem, to its planned therapy, and to
its combined treatment. Hence, his reluctance to perform combined
procedures has been based on concerns about the severity of diseases
and surgery/anesthesiology-related risks. Therefore, in order to select
the best surgical strategy for each patient, an accurate estimation of
combined risks should be carried out before treatment planning. The
increase of caseswith simultaneous surgical diseasesmade the choice
between SSC and MS surgery a frequent problem. While surgeons
should not fall into temptation for an unnecessary SSC approach,
malignancy (if associated with any other life-threatening surgical
condition) could push them towards a combined treatment. 15
On the one hand, multiple surgical approaches could potentially
affect the patient’s condition and allow progression of the untreated
problems; on the other hand, in SSC surgery complications related
to the surgical procedure for the minor disease could prevent or
delay the planned multimodal treatment for the major one. Clinical
practice nowadays is becoming increasingly specialized and the
exponential diffusion of knowledge and technology induces patients
to refer to specialists. These new advances in surgery mean that
subspecialization may be an essential requirement for an optimal
management of surgical diseases. Consequently, MS approaches
by subspecialized surgical teams could be considered mandatory
for simultaneous surgical problems. In contrast, for patients who
undergo a SSC operation, there are signiﬁcant savings in money,
time, anesthesia and hospitalization. In a study including 233 patients
Wilson showed how two, three and four minor procedures combined
in SSC surgery resulted in time and expense savings for both patients
and health-care providers. 3
In the literature there are only a few minor retrospective studies
about the SSC approach for multiple simultaneous diseases 6–12,15–37:
up to now, according to these experiences, SSC surgery has been con-
sidered a needed-treatment for an additional (most often malignant)
disease discovered during a cardiothoracic or vascular operation. In
fact, SSC surgery has beenproposed already in the 1980s for combined
treatment of pulmonary neoplasia and cardiac surgical disorders. 17,38
Several years later, Danton et al. rejected the initial concerns about
oncological outcomes after SSC surgery for lung cancer, 9 stating that
simultaneous pulmonary and cardiac surgery was associated with
acceptable post-operative morbidity and mortality rates with similar
long-term survival results.
The lack of homogeneity of patients with simultaneous surgical
diseases precludes the design of any randomized trial in order
to compare SSC surgery versus MS surgery. However, a few non-
randomized studies with a control arm (also historical) of MS surgery
have beenpresented. Luebke et al. compared patientswhounderwent
simultaneous GI surgery and elective abdominal aortic reconstruction
versus those who underwent exclusive aortic procedures. In this
study, carried out through a matched-pair analysis, no differences
were found for post-operative morbidity or mortality rate or for
length of hospital stay, 16 but the relevance of its conclusions was
weakened by the small sample size (only 42 patients in the SSC
group).
In such a wide irregular range a retrospective study seemed to be a
suitable analysis and a reliable method in order to reduce the impact
of classiﬁcation limits of these patients. Our analysis focused on
identifying patient-, disease- and treatment -related factors predictive
for an unfavorable outcome (morbidity, mortality, and hospital stay).
In order to have a comparison for this type of surgery it is necessary to
refer to the traditional (MS) surgical approach for each single disease
(neoplastic or not).
In our series morbidity and mortality rates were 24% (80/328)
and 3% (9/328), respectively. Since most procedures included major
surgery, we can safely compare our results with historical data
reported formajor surgery. Although in our analysis it is impossible to
deﬁne the speciﬁc morbidity andmortality for each single procedure,
our ﬁndings are similar to those reported both for SSC procedures 15,17
and for MS surgery. 39,40
According to our analysis of predictive factors formorbidity,mortal-
ity and hospital stay, no patient -related variables were independently
associated with an unfavorable outcome. The direct association
between older age and length of stay at univariate analysis was not
conﬁrmed in the multivariate model and this association could be
affected by surgeons’ caution towards elderly patients (Table 4).
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With regard to disease-related factors, the POSSUM operative
severity signiﬁcantly affected the post-operative ﬁndings in patients
who underwent combined surgery, in accordance with well-known
data. 13,41 The length of stay, as well as the complication rate,
increased along with the severity of the procedure (Table 4).
More signiﬁcantly, oncological surgical indication increased the
morbidity and the mortality rates: the inclusion of an oncological
surgical procedure among the combined ones represented the only
independent variable for mortality and the one with the strongest
impact on morbidity and length of stay (Table 4).
While the identiﬁcation of disease- and patient-related variables as-
sociated with outcomemay yield useful criteria for selecting patients
for SSC surgery, the identiﬁcation of treatment-related predictive
factors should be able to provide reliable criteria for choosing themost
suitable surgical strategy. Among all the treatment-related factors,
contamination level of the surgical procedure and operative time
mainly affected the post-operative outcome. Contamination of the
surgical ﬁeld emerged as a signiﬁcant predictive factor both for
morbidity and for length of hospital stay after surgery (Table 4).
With regard to the operative time, a combined surgical operation
exceeding 150 minutes seemed to present a higher risk of post-
operative complications and longer stay. This result seems to counter
the apparently protective effect identiﬁed at univariate analysis for
minimally invasive surgery, which generally requires longer operative
time. On the other hand, the same remark could lead the surgeon to
MS strategy, especially after an inappropriate preoperative planning.
Similarly, the same surgical team could be reluctant to afford different
surgical subspecialities in order to avoid longer operative time.
To the best of our knowledge, this study represents the ﬁrst attempt
to identify predictive factors for post-operative outcome after SSC
surgery. However, it was biased by some unavoidable limitations:
ﬁrstly, the sample was recruited retrospectively; hence, many data
were missing or inappropriate and much information has been
excluded. Secondly, we did not use any control group for comparison:
even though this choice allowed us to minimize selection bias in
our analysis, it obliged us to refer to historical data from published
reports. Thirdly, the analyzed sample was very heterogeneous andwe
rigorously classiﬁed patients otherwise unclassiﬁable; this weakened
the efﬁcacy of our results and did not allow us to outline well-deﬁned
suggestions.
Nevertheless, we can reasonably give some warnings to consider
before SSC surgical planning. Post-operative morbidity and mortality
of SSC surgery are acceptable and comparable toMS surgery. However,
the best surgical strategy for patients with simultaneous elective
surgical diseases should be deﬁned out of the operative room in order
to avoid any improvisation.
In order to select low-risk patients, particular attention must be
paid to oncological indication, POSSUM operative severity, contam-
ination grade, and operative time. A patient with more than one
unfavorable condition related to these factors could beneﬁt from
MS surgery.
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